Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_assertion type Assertion NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_head.
- NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_assertion description "[In function, flow cytometry, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5-ethynyl-2'-deoxyuridine (EdU) incorporation assays and animal transplantation assays demonstrated that HBXIP-enhanced cell proliferation of breast cancer through upregulating LMO4 in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_provenance.
- NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_assertion evidence source_evidence_literature NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_provenance.
- NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_assertion SIO_000772 23291272 NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_provenance.
- NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_assertion wasDerivedFrom befree-20140225 NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_provenance.
- NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_assertion wasGeneratedBy ECO_0000203 NP278141.RAvxLzisZd4rRt5Y2G4zbgnSgE5nuLqITES09in6m91cw130_provenance.